 |
With health care reform initiatives, quality measurement, and requirements for much greater accountability to numerous stakeholder groups, new questions arise constantly that need to be answered with more depth and greater insight.
Healthcare companies operate in an industry having truly unique challenges like long product development life cycles, regulated environments of different countries, complex market dynamics, etc. Our reports help these organizations to make informed business decisions in this increasingly challenging business environment.
We specialize in high-level information processing and analysis, specific to the needs of Healthcare and related industries worldwide. These reports contain analytical as well as statistical information on Healthcare industry. We thoroughly analyze new vistas being opened by the strongly growing healthcare industry like Telemedicine, Healthcare IT, Medical Devices, Medical Tourism, Health Insurance, E Health and Hospital Services.
|
|
 |
| Russian Pharma Sector Analysis |
| Sep, 2008 | Pages : 115 |
| The Russian pharmaceutical market grew 16% in 2007 as compared to 2006. The Russian pharmaceutical market is forecasted to grow at a CAGR of 14.36% by 2012....
read more |
|
Buy Now
US$ 1100.00 550.00
|
|
|
|
 |
| Indian Pharma Sector Analysis |
| Jan, 2008 | Pages : 100 |
| Around 67 Million Indians are expected to be above 67 years of age by 2011. This age group spends around 3 to 4 times more on drugs than those in younger age groups, thus fuelling the market growth....
read more |
|
|
|
|
.jpg) |
| Global Vaccine Market Outlook (2007-2010) |
| Nov, 2007 | Pages : 135 |
| Growing at the rate of 16.52%, global vaccine market is expected to reach US$ 21.05 Billion by 2010. Flu vaccines have huge demand at present and all major vaccine manufacturers are investing in it....
read more |
|
Buy Now
US$ 1600.00 800.00
|
|
|
.jpg) |
| Indian Biotechnology Market Outlook (2006) |
| Feb, 2007 | Pages : 90 |
| Growing at 29% from the year 2005, Indian Biotechnology industry is likely to touch US$ 5 Billion by the end of 2010. India will emerge as a key destination for clinical trials & stem cell research....
read more |
|
Buy Now
US$ 1400.00 700.00
|
|
|
|
|
|
|
|
 |
|
|